Cipher Pharmaceuticals$CPH
11 research articles
Research Articles
Cipher Pharmaceuticals ($CPH.TO) Q4'25 & FY25 Operating Results Snapshot.
Cipher Pharmaceuticals ($CPH) • By Divergent Capital 7651 • 2026-03-16
Q1'26 Idea Inventory, Part 1: $CPH.TO, $RCI.B, $SNAP, $HON.
Cipher Pharmaceuticals ($CPH) • By Divergent Capital 7651 • 2026-02-18
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF): Specialty Pharmaceuticals Focused on Dermatology Products
Cipher Pharmaceuticals ($CPH) • By Planet MicroCap • 2024-08-21
UPDATE: Cipher Pharmaceuticals - Incidental discovery involving piclidenoson in pre-clinical studies for the treatment of Lowe Syndrome
Cipher Pharmaceuticals ($CPH) • By Leftfield Investing • 2023-11-04
Cipher Pharmaceuticals - Piclidenoson
Cipher Pharmaceuticals ($CPH) • By Leftfield Investing • 2023-12-05
UPDATE: Cipher Pharmaceuticals - Sun Pharmaceuticals has officially begun marketing of Absorica LD in Canada as of early December
Cipher Pharmaceuticals ($CPH) • By Leftfield Investing • 2023-12-23
Just look at Cipher Pharmaceuticals
Cipher Pharmaceuticals ($CPH) • By Leftfield Investing • 2025-06-18
Cipher Pharmaceuticals: Write-Up Preview
Cipher Pharmaceuticals ($CPH) • By Divergent Capital 7651 • 2024-05-13
Cipher Pharmaceuticals: A High ROIC Legacy Business at a Fair Price with a Free Call-Option on Two Unpriced Catalysts
Cipher Pharmaceuticals ($CPH) • By Divergent Capital 7651 • 2024-05-19
Estimate of Cipher Pharmaceuticals' Potential Future Operating Income Post-Natroba Acquisition.
Cipher Pharmaceuticals ($CPH) • By Divergent Capital 7651 • 2024-08-12
Notes from Cipher Pharmaceuticals' Planet Microcap Interview dated 21 August 2024.
Cipher Pharmaceuticals ($CPH) • By Divergent Capital 7651 • 2024-08-22
